超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

美國Cancer Genetics, Inc. (CGI)
癌癥遺傳學(xué)公司（CGI）是一個(gè)個(gè)性化的醫(yī)藥等新興的領(lǐng)導(dǎo)者，產(chǎn)品和服務(wù)，使癌癥診斷和治療是針對(duì)具體個(gè)人的遺傳特征。成立于1999年由世界知名Dr. R.S.K. Chaganti博士.產(chǎn)品正在共同閘道介面發(fā)展將轉(zhuǎn)變癌癥患者管理，提高治療效果，并減少醫(yī)療費(fèi)用。共同閘道介面的先進(jìn)的測(cè)試結(jié)果，以及最先進(jìn)的參考實(shí)驗(yàn)室國家提供基因組信息，病人和他們的醫(yī)生最需要的 - 診斷，監(jiān)測(cè)和通報(bào)癌癥治療。

An Emerging Leader In Cancer Diagnostics

Cancer Genetics, Inc. (CGI) is an emerging leader in personalized medicine, with products and services that enable cancer diagnostics and treatment that are tailored to the specific genetic profile of the individual.

Products being developed at CGI are poised to transform cancer patient management, increase treatment efficacy, and reduce healthcare costs. CGI’s cutting-edge proprietary tests and state of the art reference lab provide genomic information where patients and their physicians need it most – to diagnose, monitor and inform cancer treatment.

Founded in 1999 by world-renowned cytogeneticist Dr. R.S.K. Chaganti, CGI’s scientific advisory board includes leading specialists in clinical cytogenetics, as well as significant thought leaders capable of driving adoption in the tri-state area.

The company has been built on world-class scientific knowledge and IP in solid and blood-borne cancers, as well as strong academic relationships with major cancer centers such as Memorial Sloan-Kettering and the National Cancer Institute.